研究进展关于LncRNA HCP5通过向MiR-27b-3p调节高变性痕的研究进展
Jianping He1, Lanzhen Xie2, Zhuo Zhang3
1Department of Dermatology and Venereology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Skin pharmacology and physiology
|October 23, 2025
概括
长非编码RNA HCP5在缩性痕中被上调,并影响纤维细胞的行为. 它针对miR-27b-3p,影响痕发育,并提供潜在的治疗途径.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 纤维化研究 纤维化研究
背景情况:
- 过度缩性痕是纤维细胞过度生长的纤维性疾病.
- 了解痕形成机制对于改善治疗结果至关重要.
- 长非编码RNA (lncRNA) HCP5在缩性痕发育中的作用需要进一步研究.
研究的目的:
- 为了研究 lncRNA HCP5 在人类缩性痕中的临床意义.
- 探索 lncRNA HCP5 在纤维细胞行为中的作用背后的潜在机制.
- 为了确定lncRNA HCP5和miR-27b-3p在高变性痕形成中的关系.
主要方法:
- 量化实时PCR用于评估63名患者的HCP5表达.
- 分析了人类多变性痕纤维细胞 (HSF) 的细胞行为 (活力,迁移,亡).
- 双露西法酶记者测定证实了lncRNA HCP5和miR-27b-3p之间的相互作用.
主要成果:
- 在高性痕组织中,LncRNA HCP5的调节显著上升.
- 沉默 lncRNA HCP5 降低了 HSF 活力和迁移,同时促进了细胞亡.
- miR-27b-3p被下调,与HCP5负相关,并参与调节细胞行为.
结论:
- LncRNA HCP5在人类高性痕的生物行为中发挥着重要作用.
- LncRNA HCP5通过准microRNAmiR-27b-3p.p来发挥其作用.
- 调节lncRNA HCP5/miR-27b-3p轴可能为过敏性痕提供治疗策略.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
399
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
399
Clinical Applications of Epidermal Stem Cells
3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K

